Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer

2.

Yaginuma

Y

,

Yamashita

T

,

Ishiya

T

,

Morizaki

A

,

Katoh

Y

,

Takahashi

T

.

Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers

.

Mol Carcinog

.

2000

;

27

(

2

):

110

–

6

.

3.

Guan

B

,

Mao

TL

,

Panuganti

PK

,

Kuhn

E

,

Kurman

RJ

,

Maeda

D

.

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

.

Am J Surg Pathol

.

2011

;

35

(

5

):

625

–

32

.

4.

Saegusa

M

,

Hashimura

M

,

Yoshida

T

,

Okayasu

I

.

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

.

Br J Cancer

.

2001

;

84

(

2

):

209

–

17

.

5.

Esteller

M

,

García

A

,

Martínez-Palones

JM

,

Xercavins

J

,

Reventós

J

.

The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer

.

Eur J Cancer

.

1997

;

33

(

10

):

1572

–

7

.

6.

An

HJ

,

Lee

YH

,

Cho

NH

,

Shim

JY

,

Kim

JY

,

Lee

C

.

Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27

.

Histopathology

.

2002

;

41

(

5

):

437

–

45

.

7.

Wiegand

KC

,

Lee

AF

,

Al-Agha

OM

,

Chow

C

,

Kalloger

SE

,

Scott

DW

.

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

.

J Pathol

.

2011

;

224

(

3

):

328

–

33

.

8.

Unoki

M

,

Brunet

J

,

Mousli

M

.

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis

.

Biochem Pharmacol

.

2009

;

78

(

10

):

1279

–

88

.

9.

Mori

T

,

Ikeda

DD

,

Yamaguchi

Y

,

Unoki

M

NIRF Project

.

NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape

.

FEBS Lett

.

2012

;

586

(

11

):

1570

–

83

.

10.

Kofunato

Y

,

Kumamoto

K

,

Saitou

K

,

Hayase

S

,

Okayama

H

,

Miyamoto

K

.

UHRF1 expression is upregulated and associated with cellular proliferation in colorectal cancer

.

Oncol Rep

.

2012

;

28

(

6

):

1997

–

2002

.

11.

Yang

C

,

Wang

Y

,

Zhang

F

,

Sun

G

,

Li

C

,

Jing

S

.

Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma

.

Mol Biol Rep

.

2013

;

40

(

9

):

5225

–

35

.

12.

Zhou

L

,

Zhao

X

,

Han

Y

,

Lu

Y

,

Shang

Y

,

Liu

C

.

Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis

.

FASEB J

.

2013

;

27

(

12

):

4929

–

39

.

13.

Lorenzato

M

,

Caudroy

S

,

Bronner

C

,

Evrard

G

,

Simon

M

,

Durlach

A

.

Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions

.

Hum Pathol

.

2005

;

36

(

10

):

1101

–

7

.

14.

Polepalli

S

,

George

SM

,

Valli Sri Vidya

R

,

Rodrigues

GS

,

Ramachandra

L

,

Chandrashekar

R

.

Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain

.

Int J Biochem Cell Biol

.

2019

;

114

:

105558

.

15.

Bronner

C

,

Krifa

M

,

Mousli

M

.

Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis

.

Biochem Pharmacol

.

2013

;

86

(

12

):

1643

–

9

.

16.

Nady

N

,

Lemak

A

,

Walker

JR

,

Avvakumov

GV

,

Kareta

MS

,

Achour

M

.

Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein

.

J Biol Chem

.

2011

;

286

(

27

):

24300

–

11

.

17.

Greiner

VJ

,

Kovalenko

L

,

Humbert

N

,

Richert

L

,

Birck

C

,

Ruff

M

.

Site-selective monitoring of the interaction of the SRA domain of UHRF1 with target DNA sequences labeled with 2-aminopurine

.

Biochemistry

.

2015

;

54

(

39

):

6012

–

20

.

18.

Rajakumara

E

,

Wang

Z

,

Ma

H

,

Hu

L

,

Chen

H

,

Lin

Y

.

PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression

.

Mol Cell

.

2011

;

43

(

2

):

275

–

84

.

19.

Bashtrykov

P

,

Jankevicius

G

,

Jurkowska

RZ

,

Ragozin

S

,

Jeltsch

A

.

The UHRF1 protein stimulates the activity and specificity of the maintenance DNA methyltransferase DNMT1 by an allosteric mechanism

.

J Biol Chem

.

2014

;

289

(

7

):

4106

–

15

.

20.

Arima

Y

,

Hirota

T

,

Bronner

C

,

Mousli

M

,

Fujiwara

T

,

Niwa

S

.

Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition

.

Genes Cells

.

2004

;

9

(

2

):

131

–

42

.

21.

Jeanblanc

M

,

Mousli

M

,

Hopfner

R

,

Bathami

K

,

Martinet

N

,

Abbady

AQ

.

The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle

.

Oncogene

.

2005

;

24

(

49

):

7337

–

45

.

22.

Unoki

M

,

Nishidate

T

,

Nakamura

Y

.

ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain

.

Oncogene

.

2004

;

23

(

46

):

7601

–

10

.

23.

Jin

W

,

Chen

L

,

Chen

Y

,

Xu

SG

,

Di

GH

,

Yin

WJ

.

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

.

Breast Cancer Res Treat

.

2010

;

123

(

2

):

359

–

73

.

24.

Sabatino

L

,

Fucci

A

,

Pancione

M

,

Carafa

V

,

Nebbioso

A

,

Pistore

C

.

UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression

.

Oncogene

.

2012

;

31

(

49

):

5061

–

72

.

25.

Sheng

Y

,

Wang

H

,

Liu

D

,

Zhang

C

,

Deng

Y

,

Yang

F

.

Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma

.

Gynecol Oncol

.

2016

;

140

(

1

):

145

–

51

.

26.

Bronner

C

,

Achour

M

,

Arima

Y

,

Chataigneau

T

,

Saya

H

,

Schini-Kerth

VB

.

The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future

.

Pharmacol Ther

.

2007

;

115

(

3

):

419

–

34

.

27.

Li

Y

,

Mori

T

,

Hata

H

,

Homma

Y

,

Kochi

H

.

NIRF induces G1 arrest and associates with Cdk2

.

Biochem Biophys Res Commun

.

2004

;

319

(

2

):

464

–

8

.

28.

Mori

T

,

Ikeda

DD

,

Fukushima

T

,

Takenoshita

S

,

Kochi

H

.

NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor

.

Cell Cycle

.

2011

;

10

(

19

):

3284

–

99

.

29.

Iguchi

T

,

Ueda

M

,

Masuda

T

,

Nambara

S

,

Kidogami

S

,

Komatsu

H

.

Identification of UHRF2 as a negative regulator of epithelial-mesenchymal transition and its clinical significance in esophageal squamous cell carcinoma

.

Oncology

.

2018

;

95

(

3

):

179

–

87

.

30.

Varley

KE

,

Mitra

RD

.

Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples

.

Genome Res

.

2010

;

20

(

9

):

1279

–

87

.

31.

Wang

F

,

Zhang

P

,

Ma

Y

,

Yang

J

,

Moyer

MP

,

Shi

C

.

NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA

.

Cancer Lett

.

2012

;

314

(

2

):

223

–

31

.

32.

Lu

S

,

Yan

D

,

Wu

Z

,

Jiang

T

,

Chen

J

,

Yuan

L

.

Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer

.

Oncol Rep

.

2014

;

31

(

4

):

1802

–

10

.

33.

Nishida

M

,

Kasahara

K

,

Kaneko

M

,

Iwasaki

H

,

Hayashi

K

.

[Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]

.

Nihon Sanka Fujinka Gakkai Zasshi

.

1985

;

37

(

7

):

1103

–

11

.

34.

Köhler

G

,

Milstein

C

.

Continuous cultures of fused cells secreting antibody of predefined specificity

.

Nature

.

1975

;

256

(

5517

):

495

–

7

.

35.

Mori

T

,

Li

Y

,

Hata

H

,

Kochi

H

.

NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein

.

FEBS Lett

.

2004

557

1–3

209

14

.

36.

Maehama

T

,

Dixon

JE

.

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

.

J Biol Chem

.

1998

;

273

(

22

):

13375

–

8

.

37.

Salvesen

HB

,

MacDonald

N

,

Ryan

A

,

Jacobs

IJ

,

Lynch

ED

,

Akslen

LA

.

PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma

.

Int J Cancer

.

2001

;

91

(

1

):

22

–

6

.

38.

Alhosin

M

,

Omran

Z

,

Zamzami

MA

,

Al-Malki

AL

,

Choudhry

H

,

Mousli

M

.

Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer

.

J Exp Clin Cancer Res

.

2016

;

35

(

1

):

174

.

39.

Gray

RS

,

Cheung

KJ

,

Ewald

AJ

.

Cellular mechanisms regulating epithelial morphogenesis and cancer invasion

.

Curr Opin Cel Biol

.

2010

;

22

(

5

):

640

–

50

.

40.

Friedl

P

,

Gilmour

D

.

Collective cell migration in morphogenesis, regeneration and cancer

.

Nat Rev Mol Cel Biol

.

2009

;

10

(

7

):

445

–

57

.

41.

Rørth

P

.

Fellow travellers: emergent properties of collective cell migration

.

EMBO Rep

.

2012

;

13

(

11

):

984

–

91

.

42.

Daskalos

A

,

Oleksiewicz

U

,

Filia

A

,

Nikolaidis

G

,

Xinarianos

G

,

Gosney

JR

.

UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer

.

Cancer

.

2011

;

117

(

5

):

1027

–

37

.

43.

Dubois

F

,

Keller

M

,

Calvayrac

O

,

Soncin

F

,

Hoa

L

,

Hergovich

A

.

RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1/RhoB pathway

.

Cancer Res

.

2016

;

76

(

6

):

1627

–

40

.

44.

Wan

X

,

Yang

S

,

Huang

W

,

Wu

D

,

Chen

H

,

Wu

M

.

UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy

.

J Exp Clin Cancer Res

.

2016

;

35

:

34

.

45.

Wang

F

,

Yang

YZ

,

Shi

CZ

,

Zhang

P

,

Moyer

MP

,

Zhang

HZ

.

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer

.

Ann Surg Oncol

.

2012

;

19

(

8

):

2753

–

62

.

46.

Qin

Y

,

Wang

J

,

Gong

W

,

Zhang

M

,

Tang

Z

,

Zhang

J

.

UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest

.

Oncol Rep

.

2014

;

31

(

6

):

2635

–

43

.

47.

Zhang

Y

,

Huang

Z

,

Zhu

Z

,

Zheng

X

,

Liu

J

,

Han

Z

.

Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1

.

PLoS One

.

2014

;

9

(

10

):

e104252

.

48.

Cui

L

,

Chen

J

,

Zhang

Q

,

Wang

X

,

Qu

J

,

Zhang

J

.

Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells

.

Mol Cel Biochem

.

2015

400

1–2

223

32

.

49.

Yan

F

,

Shao

LJ

,

Hu

XY

.

Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth

.

Asian Pac J Cancer Prev

.

2015

;

16

(

4

):

1343

–

8

.

50.

Li

XL

,

Xu

JH

,

Nie

JH

,

Fan

SJ

.

Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer cells

.

Oncol Rep

.

2012

;

28

(

1

):

375

–

83

.

51.

Merritt

MA

,

Cramer

DW

.

Molecular pathogenesis of endometrial and ovarian cancer

.

Cancer Biomark

.

2010

9

1–6

287

305

.

52.

Banasavadi-Siddegowda

YK

,

Russell

L

,

Frair

E

,

Karkhanis

VA

,

Relation

T

,

Yoo

JY

.

PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells

.

Oncogene

.

2017

;

36

(

2

):

263

–

74

.

53.

Zhou

L

,

Shang

Y

,

Jin

Z

,

Zhang

W

,

Lv

C

,

Zhao

X

.

UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation

.

Cancer Biol Ther

.

2015

;

16

(

8

):

1241

–

51

.

54.

Ma

J

,

Peng

J

,

Mo

R

,

Ma

S

,

Wang

J

,

Zang

L

.

Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma

.

Biochem Biophys Res Commun

.

2015

;

464

(

1

):

147

–

53

.

55.

Guan

D

,

Factor

D

,

Liu

Y

,

Wang

Z

,

Kao

HY

.

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein

.

Oncogene

.

2015

;

34

(

40

):

5206

.

56.

Wu

Z

,

Cho

H

,

Hampton

GM

,

Theodorescu

D

.

Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis

.

Neoplasia

.

2009

;

11

(

1

):

66

–

76

.

57.

Mousli

M

,

Hopfner

R

,

Abbady

AQ

,

Monté

D

,

Jeanblanc

M

,

Oudet

P

.

ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells

.

Br J Cancer

.

2003

;

89

(

1

):

120

–

7

.